Dexa Group Library

  • Home
  • Information
  • News
  • Help
  • Librarian
  • Member Area
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}

Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 4 from your keywords: subject="Rhinofed"
cover
SERPINA1 Gene Variants in Granulomatosis with Polyangiitis
Comment Share
Hadzik-Blaszczyk M

Alpha-1 antitrypsin (A1AT) deficiency is one of the most common genetic disorders in Caucasian population. There is a link between granulomatosis with polyangiitis (GPA) and most frequent variants of SERPINA1 gene encoding severe alpha-1 antitripsin deficiency

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
A Comparative Tolerance Study of Terfenadine - Pseudoephedrine Combination Ta…
Comment Share
Stroh JE

In this multicentre , double-blind, randomized, parallel group study, 315 patients with allergic or vasomotor rhinitis were treated on a twice daily dosing schedule with either a 60 mg terfenadine -120 mg pseudoephedrine hydrochloride combination or 120 mg pseudoephedrine hydrochloride (extended release) for 2 weeks. Noclinically significant differences between the two groups were noted in body…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
Effects of terfenadine and pseudoephedrine, alone and in combination in a nas…
Comment Share
Henauer S

The effects of terfenadine and pseudoephedrine, alone and in combination, have been assessed in a nasal provocation test and in perennial rhinitis.

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
cover
SERPINA1 and MAN1B1 polymorphisms are not linked to severe liver disease in a…
Comment Share
Joly P

Fifteen to twenty percent of alpha-1 antitrypsin deficiency patients (A1ATD) have a severe liver outcome (portal hypertension -PHT) during childhood. Since they all share the same ZZ SERPINA1 genotype and that environmental factors such as alcohol cannot be advanced, the presence of modifier genes is now well recognized. SNPs located on the SERPINA1 and MAN1B1 genes have already been tes…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
Availability1
Add to basket
MARC DownloadCite
Dexa Group Library
  • Information
  • Services
  • Librarian
  • Member Area

About Us

This digital catalog is dedicated to all members of DEXAN as part of our ongoing effort to provide practical, effective, efficient, up-to-date, and comprehensive information services that can be accessed anytime and anywhere.We have developed this website as a medium for information sharing and user interaction. We are committed to continuous innovation in order to become a reliable source of information that meets the evolving needs of DEXAN. Our mission includes supporting literacy culture enhancement programs and improving service quality.Inspired by the concept of The Dynamic Library, we are constantly evolving to optimize our role in supporting and facilitating research, education, preservation, information, and recreation—while striving to deliver excellent service.This platform also offers a guide on how to independently access information through this digital catalog.

Search

start it by typing one or more keywords for title, author or subject

Keep SLiMS Alive Want to Contribute?

© 2026 — Senayan Developer Community

Powered by SLiMS
Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search
Where do you want to share?